Fetal Fibronectin Test Market: Introduction

  • Prematurity is one of the leading causes of neonatal deaths worldwide. More than one million newborns die of prematurity each year and those who are able to survive suffer from several disabilities. According to an NIH report, it was found that around 15 million babies born worldwide are premature with increasing rates over past few decades. This indicates that the use of fetal fibronectin test is expected to increase gradually in the near future.
  • Fetal fibronectin is a protein that acts as a biological glue and helps in keeping the amniotic sac attached to the lining of the uterus. If a disruption occurs in this connection due to an infection, inflammation, or other reasons, the fetal fibronectin is released into the cervix along with other cervicovaginal secretions.
  • Fetal fibronectin test is generally performed to rule out risks of preterm labor. A swab is taken from the cervical lining and is analyzed for the presence of fibronectin. If the test comes out positive, the clinician expects a premature birth and prepares to handle the premature labor accordingly, for example, by administering drugs to enhance the baby's lung maturity.

Get a Glimpse of the In-Depth Analysis through our Fetal Fibronectin Test Market Report Brochure

Key Drivers and Restraints of Global Fetal Fibronectin Test Market

  • Some of the major growth drivers for the fetal fibronectin test market are high incidence rate of premature births, increase in age of maternal population, high birth rates in less developed and developing economies, increase in awareness about prenatal and neonatal care, and rise in demand for advanced and/or improved measures for prenatal and neonatal care.
  • However, extremely low birth rates in some of the developed economies may restrain the fetal fibronectin test market in the near future. Furthermore, growth in emerging economies, increased government support, and relative funding is expected to continue boosting the fetal fibronectin test market’s growth in the next few years.
  • Childbirth that occurs before 37 weeks or 259 days of normal gestation period is referred to as preterm birth. Such births have been rising in the recent past due to increase in maternal age of the population in various regions of the world. Preterm birth is a major factor for neonatal morbidities and mortalities, and it also has long-term adverse effects on neonatal health. Premature children have increased chances of having or developing cerebral palsy, learning disabilities, respiratory problems, sensory deficits, and many other problems when compared to children born at term.

Rapid fFN Segment to Provide Lucrative Growth Opportunities in Global Fetal Fibronectin Test Market

  • The fetal fibronectin test market can be segmented on the basis of test type and end-user
  • The test type segment can be bifurcated into a quantitative solid-phase enzyme-linked immunosorbent assay (ELISA) and a qualitative membrane immunosorbent assay (Rapid fFN).
  • Rapid fFN is expected to grow at a faster growth rate during the forecast period due to the test practicality as it gives the result within half an hour of test while ELISA-based quantitative test can take up to 4 to 48 hours to generate results.
  • Based on end-user, the fetal fibronectin test market can be segmented into hospitals, specialty clinics, and diagnostic laboratories

Expanding Operations in Future? To Get the Perfect Launch Ask for a Custom Fetal Fibronectin Test Market Report

North America to Lead Global Fetal Fibronectin Test Market

  • The global fetal fibronectin test market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is a significant market for fetal fibronectin test due to high health care expenditure and higher consciousness regarding the importance of such tests.
  • According to the National Institutes of Health (NIH) journal, in 2005, the health care costs linked to preterm births in the U.S. alone, in terms of medical and educational expenditure and lost efficiency, were more than US$ 26.2 Bn. NIH estimated that 12.9 million (9.6%) births worldwide among all births were preterm births in 2005. It was also estimated that Asia and Africa together were the largest contributors of preterm births with 11 million, accounting for 85% of the global preterm births. The higher rates of preterm births have increased the requirements for prenatal as well as neonatal care, all of which have resulted in the growth of the fetal fibronectin test market.

Key Players Operating in Global Fetal Fibronectin Test Market

Key players operating in the global fetal fibronectin test market are:

  • Hologic, Inc.
  • IQ Products
  • QIAGEN N.V.
  • Merck & Co., Inc.
  • Sera Prognostics

Global Fetal Fibronectin Test Market: Research Scope

Global Fetal Fibronectin Test Market, by Test Type

  • Rapid fFN (Fetal Fibronectin) Test
  • Quantitative ELISA-based Test

Global Fetal Fibronectin Test Market, by End-user

  • Hospitals
  • Specialty Clinics
  • Diagnostic Laboratories

Global Fetal Fibronectin Test Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Fetal Fibronectin Test Market

Pre Book